Reig Timeline

1929

1929

Foundation in Barcelona (Spain) by the pharmacist Ramon Reig Jofre. Current CEO is the third generation of the Reig family.

1964

1964-1999

Creation of a portfolio of prescription and OTC products in dermatology and respiratory through the combination of own developments and various acquisitions in Spain

1989

1978-2009

Specialization in sterile injectables

  • 1978 First freeze dryer
  • 1998 Acquisition of Sant Joan Despí plant
  • 2009 New vial plant
2009

2000-2004

Antibiotic specialization

  • 2000 acquisition of the Toledo plant
  • 2003 Construction of the Cephalosporin plant
  • 2004 Acquisition of antibiotic licenses Anaclosil, Pulmictan, Ardine and ArdineClav
2013

2009

  • Acquisition of Swedish company Bioglan AB
  • From export to direct international presence
2015

2014

  • Creation of RJ UK to centralize Reig Jofre’s commercial activity in the United Kingdom
  • Creation of RJ Europe, a joint-venture in Singapore for marketing in ASEAN countries
  • Acquisition of an international logistics center in Spain
2016

2015

Reig Jofre merges with the company Natraceutical, a benchmark in Europe in the sector of nutritional supplements for sale in pharmacies through its Forté Pharma brand and becomes the 5th Spanish pharmaceutical company by turnover, listed on the Spanish stock market

2017

2016-2017

Marketing of injectable products begins in Japan and Forté Pharma products in Hong Kong and Macao.
Industrial development of biotechnological assets.
Marketing of antibiotics begins in the Philippines.

2018

2018

Constitution of the joint venture Syna Therapeutics, for the development of biopharmaceutical products in the field of biosimilars and innovative molecules.
Marketing of injectable products begins in Indonesia.

2019

2019

Acquisition of the Joint Health and Pain product portfolio from Bioiberica company.
Collaboration agreements in the development of new products.
Market entry in South Korea with the injectable for hospital use Remifentanil.